2013
DOI: 10.1016/j.adengl.2013.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Nevoid Basal Cell Carcinoma Syndrome: Our Experience in a Pediatric Hospital

Abstract: Nevoid basal cell carcinoma (BCC) syndrome, or Gorlin syndrome, is a rare autosomal dominant disorder associated with mutations in the patched 1 gene, PTCH1. It is characterized by the presence of multiple BCCs in association with disorders affecting the bones, the skin, the eyes, and the nervous system. We describe 6 cases of nevoid BCC syndrome evaluated in our department. Palmoplantar pitting was observed in all 6 patients, multiple BCCs in 5 patients (83%), skeletal anomalies in 3 patients (50%), and odont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 18 publications
0
9
0
2
Order By: Relevance
“…The classic treatment for basal cell carcinomas is surgical excision, but CO 2 laser, electrocauterization, cryotherapy, and photodynamic therapy may be used when too many lesions are present and when recurrence occurs. In addition, imiquimod cream 5%, topical 5-fluorouracil and vismodegib in locally-advanced and metastatic forms are other treatment options (9,10). We initiated imiquimod cream 5% three days a week in our patient, observed regression in the lesions after one month, and still continue this treatment.…”
Section: Discussionmentioning
confidence: 98%
“…The classic treatment for basal cell carcinomas is surgical excision, but CO 2 laser, electrocauterization, cryotherapy, and photodynamic therapy may be used when too many lesions are present and when recurrence occurs. In addition, imiquimod cream 5%, topical 5-fluorouracil and vismodegib in locally-advanced and metastatic forms are other treatment options (9,10). We initiated imiquimod cream 5% three days a week in our patient, observed regression in the lesions after one month, and still continue this treatment.…”
Section: Discussionmentioning
confidence: 98%
“…PDT is a well‐recognized treatment for adults with multiple BCCs, providing excellent clinical and cosmetic outcomes, with a cure rate ranging from 78% to 98% . Children with BCNS have been successfully treated with PDT .…”
Section: Methodsmentioning
confidence: 99%
“…Vakalarda genellikle predispozisyon yaratan kseroderma pigmentozum, nevoid bazal hüc-reli karsinom sendromu (Gorlin sendromu) gibi nedenler yer almaktadır (Tablo 2). 16,17 Nevüs sebaseus da nadir de olsa predispozisyon yaratan diğer bir nedendir. 18 Meksika'da yapılan bir araştırmanın sonucuna göre BCC pediatrik yaş grubunda tüm tü-mörlerin %0,24'ünü ve deri tümörlerinin %13'ünü oluşturmaktadır.…”
Section: Bazal Hücreli̇ Karsi̇nomunclassified
“…Çocukların çoğu saplı fibroepitelyoma benzeri BCC lezyonları ile başvurur. 16,17 BCC için risk faktörleri; güneş yanığı, UV maruziyeti, renkli göz-açık renk saç rengine sahip olmak, iyonize radyasyon, immünsup-resyon, arsenik gibi kimyasal madde maruziyetinin olmasıdır. Tümörün gelişmesi için UV maruziyetinin dekadlar boyunca olması gerekmektedir.…”
Section: Bazal Hücreli̇ Karsi̇nomunclassified